Literature DB >> 18568446

Comparison of the expression profiles of promastigotes and axenic amastigotes in Leishmania donovani using serial analysis of gene expression.

Qiaoli Li1, Yangxing Zhao, Bing Ni, Chenjiang Yao, Ying Zhou, Wangjie Xu, Zhaoxia Wang, Zhongdong Qiao.   

Abstract

In this study, we examined the transcriptome of Leishmania donovani promastigotes and axenic amastigotes to identify differentially regulated mRNAs utilizing the serial analysis of gene expression (SAGE). The axenic culture of amastigotes was initiated from stationary phase promastigotes. Transformation from promastigote to amastigote occurred when cultures in Medium 199 (pH 5.5), supplemented with 20% (v/v) fetal bovine serum, were transferred from 26 degrees C to 37 degrees C. A total of 20,299 and 20,132 tags were generated from promastigote and amastigote libraries, respectively. The containing unique genes identified in these two SAGE libraries were 8,615 and 7,835, respectively. Characteristics of the expressed genes' frequency distribution were remarkably similar in both libraries: the most abundant tags (frequency>or=20), whose levels were equal to or >1.3% of the identified tags, constituted >23% of the total sequenced tags. Correspondingly, 75.72% or 71.65% of the genes accounted for those tags present at low abundance (frequency=1) contributed only 32.13% or 27.89% of the total tags. A total of 968 genes (11.2% of the total genes in promastigotes and 12.4% in amastigotes) were recorded to have statistically different transcript levels between promastigotes and axenic amastigotes. Of the 968 distinct total genes, there are 326 promastigote-enriched transcripts and 642 amastigote-enriched mRNAs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568446     DOI: 10.1007/s00436-008-1048-7

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  22 in total

1.  Fusion of host cell secondary lysosomes with the parasitophorous vacuoles of Leishmania mexicana-infected macrophages.

Authors:  J Alexander; K Vickerman
Journal:  J Protozool       Date:  1975-11

2.  Expression profiling by whole-genome interspecies microarray hybridization reveals differential gene expression in procyclic promastigotes, lesion-derived amastigotes, and axenic amastigotes in Leishmania mexicana.

Authors:  Timothy R Holzer; W R McMaster; James D Forney
Journal:  Mol Biochem Parasitol       Date:  2006-01-06       Impact factor: 1.759

3.  Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vitro.

Authors:  K P Chang; D M Dwyer
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

4.  Using the transcriptome to annotate the genome.

Authors:  Saurabh Saha; Andrew B Sparks; Carlo Rago; Viatcheslav Akmaev; Clarence J Wang; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

5.  Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: the Leishmania genome is constitutively expressed.

Authors:  Kirk Leifso; Gabriela Cohen-Freue; Nisha Dogra; Angus Murray; W Robert McMaster
Journal:  Mol Biochem Parasitol       Date:  2006-12-08       Impact factor: 1.759

6.  A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species.

Authors:  Márcia Cristina Aquino Teixeira; Regilene de Jesus Santos; Romina Barreto Sampaio; Lain Pontes-de-Carvalho; Washington L C dos-Santos
Journal:  Parasitol Res       Date:  2002-07-06       Impact factor: 2.289

7.  Differential gene expression analysis in antimony-unresponsive Indian kala azar (visceral leishmaniasis) clinical isolates by DNA microarray.

Authors:  N Singh; R Almeida; H Kothari; P Kumar; G Mandal; M Chatterjee; S Venkatachalam; M K Govind; S K Mandal; S Sundar
Journal:  Parasitology       Date:  2007-02-19       Impact factor: 3.234

8.  Axenic cultivation and partial characterization of Leishmania braziliensis amastigote-like stages.

Authors:  J M Balanco; E M Pral; S da Silva; A T Bijovsky; R A Mortara; S C Alfieri
Journal:  Parasitology       Date:  1998-02       Impact factor: 3.234

9.  Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani.

Authors:  Y Saar; A Ransford; E Waldman; S Mazareb; S Amin-Spector; J Plumblee; S J Turco; D Zilberstein
Journal:  Mol Biochem Parasitol       Date:  1998-09-01       Impact factor: 1.759

10.  Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics.

Authors:  Alain Debrabant; Manju B Joshi; Paulo F P Pimenta; Dennis M Dwyer
Journal:  Int J Parasitol       Date:  2004-02       Impact factor: 3.981

View more
  11 in total

1.  Frequency of MDR1-related p-gp overexpression in Greek Leishmania isolates.

Authors:  Johannes Austrup; Pantelis Ntais; Vasiliki Christodoulou; Jean-Pierre Dedet; Francine Pratlong; Maria Antoniou
Journal:  Parasitol Res       Date:  2014-02-07       Impact factor: 2.289

2.  Evidence of RNA editing in Leishmania braziliensis promastigotes.

Authors:  César Ramírez; Concepción Puerta; Jose M Requena
Journal:  Parasitol Res       Date:  2010-12-04       Impact factor: 2.289

3.  Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay.

Authors:  Manu De Rycker; Irene Hallyburton; John Thomas; Lorna Campbell; Susan Wyllie; Dhananjay Joshi; Scott Cameron; Ian H Gilbert; Paul G Wyatt; Julie A Frearson; Alan H Fairlamb; David W Gray
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

4.  In situ immunolocalization and stage-dependent expression of a secretory serine protease in Leishmania donovani and its role as a vaccine candidate.

Authors:  Rajdeep Choudhury; Partha Das; Siddhartha Kumar Bhaumik; Tripti De; Tapati Chakraborti
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

5.  Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity.

Authors:  Andrea Nühs; Manu De Rycker; Sujatha Manthri; Eamon Comer; Christina A Scherer; Stuart L Schreiber; Jean-Robert Ioset; David W Gray
Journal:  PLoS Negl Trop Dis       Date:  2015-09-25

6.  Transcriptome profiling of the fifth-stage larvae of Angiostrongylus cantonensis by next-generation sequencing.

Authors:  Lian-chen Wang; Kuang-yao Chen; Shih-hsin Chang; Li-yu Chung; Ruei-chi Richie Gan; Chien-ju Cheng; Petrus Tang
Journal:  Parasitol Res       Date:  2013-07-05       Impact factor: 2.289

7.  Temperature increase prevails over acidification in gene expression modulation of amastigote differentiation in Leishmania infantum.

Authors:  Pedro J Alcolea; Ana Alonso; Manuel J Gómez; Alicia Sánchez-Gorostiaga; Mercedes Moreno-Paz; Eduardo González-Pastor; Alfredo Toraño; Víctor Parro; Vicente Larraga
Journal:  BMC Genomics       Date:  2010-01-14       Impact factor: 3.969

8.  Application of serial analysis of gene expression to the study of the gene expression profile of Leishmania infantum chagasi promastigote.

Authors:  Adelino Soares Lima Neto; Osvaldo Pompílio de Melo Neto; Carlos Henrique Nery Costa
Journal:  J Biomed Biotechnol       Date:  2012-04-10

9.  Antileishmanial Activity of Compounds Derived from the Medicines for Malaria Venture Open Access Box Against Intracellular Leishmania major Amastigotes.

Authors:  Mozna Khraiwesh; Susan Leed; Norma Roncal; Jacob Johnson; Richard Sciotti; Philip Smith; Lisa Read; Robert Paris; Thomas Hudson; Mark Hickman; Max Grogl
Journal:  Am J Trop Med Hyg       Date:  2015-10-26       Impact factor: 2.345

10.  Moving from unsequenced to sequenced genome: reanalysis of the proteome of Leishmania donovani.

Authors:  Raja Sekhar Nirujogi; Harsh Pawar; Santosh Renuse; Praveen Kumar; Sandip Chavan; Gajanan Sathe; Jyoti Sharma; Sweta Khobragade; Janhavee Pande; Bhakti Modak; T S Keshava Prasad; H C Harsha; Milind S Patole; Akhilesh Pandey
Journal:  J Proteomics       Date:  2013-05-09       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.